Prior analysis has characterized the clonal characteristics of effector CD8 ؉ T cells specific for the prominent influenza A virus nucleoprotein (NP) and acid polymerase (PA) peptides presented by H2D b . Using a single-cell approach and determination of CDR3␤ profiles, a limited, predominantly ''public'' repertoire was found for CD8 ؉ D b NP366 ؉ V␤8.3 ؉ cells, whereas diverse and ''private'' T cell antigen receptor (TCR)␤ clonotypes were typical of the CD8 ؉ D b PA224 ؉ V␤7 ؉ response. This single-cell approach has now been used to relate the contributions of particular clonotypes (or affinities) to high-avidity TCRs, as defined by binding under conditions of limiting tetramer availability. At least by the measure of CDR3␤ usage, no difference could be found between total and high-avidity populations in the spectrum of TCR-pMHC affinities throughout the limited, and relatively public, CD8 ؉ D b NP366 ؉ V␤8.3 ؉ populations. Conversely, the more even (by clone size), diverse, and private CD8 ؉ D b PA224 ؉ V␤7 ؉ response was characterized by the clear partitioning of the largest T cell clones in the high-avidity compartment. These results suggest that the relatively constrained CD8 ؉ D b NP366 ؉ V␤8.3 ؉ set utilizes a relatively narrow range of affinities, whereas the broader CD8 ؉ D b PA224 ؉ V␤7 ؉ response is induced at a range of TCR-pMHC affinities. Thus, whereas TCR sequence (or affinity) appears to contribute substantially to the avidity profile of diverse virus-specific CD8 ؉ populations, other mechanisms may be prominent where the TCR spectrum is more limited.
H igh-avidity CD8
ϩ T cells are thought to play a major role in terminating viral infections (1, 2) and eliminating tumor cells (3, 4) . By one estimate, at least, the high-avidity T cells may be 1,000-fold more effective in virus clearance than low-avidity T cells with the same epitope specificity (1) . Several factors have been shown to influence the overall T cell-target cell-avidity equation, including T cell antigen receptor (TCR) affinity for the pMHC epitope (5) , the strength of the CD8␤-MHC interaction (6) (7) (8) , the localization and multimerization of the TCR␣␤ dimers (9) , the recruitment of signaling molecules to the TCR-CD3 complex (10, 11) , and the contribution of accessory molecules in lipid rafts (9, 12) . However, the part played by each of these factors in the overall avidity profile is far from clear. The present analysis focuses on the contribution of TCR (defined by CDR3␤ sequence) to the avidity characteristics of two prominent CD8
ϩ T cell responses after respiratory infection of C57BL͞6 (H2K b D b ) with influenza A viruses. These H2D brestricted responses (13, 14) to the viral nucleoprotein (NP) and the acid polymerase (PA) tend to be equivalent in magnitude after primary infection, but the extent of clonal expansion subsequent to secondary challenge is much greater for the CD8 ϩ D b NP 366 ϩ set (15, 16) . The reason for this result may rest in differential profiles of antigen presentation (17) . An inverse correlation is found when the analysis focuses on the quality of the response, with the CD8 ϩ D b PA 224 ϩ cells producing higher levels of IFN-␥, TNF-␣, and IL-2 (18, 19) .
Most in vivo analyses of virus-specific CD8
ϩ T cell response profiles concentrate on population dynamics (20) . Developing a better understanding of the TCR-pMHC avidity equation requires a move from the analysis of bulk populations to individual clones. Although avidity characteristics can readily be determined for TCR transgenic mice and hybridoma cell lines, the clonal dissection of an in vivo immune response at the population level is challenging. The combination of single-cell sorting of tetramer-positive cells followed by PCR analysis has allowed detailed dissection of the inf luenza virus-specific CD8 ϩ D b NP 366 ϩ V␤8.3 ϩ and CD8 ϩ D b PA 224 ϩ V␤7 ϩ T cell responses. Clonality in this system has been defined by the patterns of individual TCR CDR3␤ usage within a particular TCRV␤ staining profile (21, 22) . Whereas the CD8 ϩ D b PA 224 ϩ V␤7 ϩ cells express a variety of J␤ elements and a predominant CDR3␤ loop of 6 amino acids (21) , the CD8 ϩ D b NP 366 ϩ V␤8.3 ϩ repertoire is both more limited in diversity and characterized by high frequency public (shared between different individuals) clonotypes by using J␤2.2 and a modal CDR3␤ loop of 9 amino acids (22) . The present experiments use a tetramer dilution approach to analyze the contribution of particular TCR sequences to TCR-pMHC avidity within the clonally distinct
The TCR sequence will, of course, be the only variable determining affinity at the level of the individual TCR-pMHC interaction.
Based on the published evidence (5, (23) (24) (25) , it is reasonable to think that low concentrations of tetramer will be bound selectively by T cells expressing high-avidity TCRs. Thus, tetramer dilution combined with single-cell PCR has the potential to provide information on TCR clonal diversity for CD8 ϩ T cells within both the total antigen-specific pool (stained with tetramers at saturating levels) and the high-avidity set (stained at limiting tetramer dilutions). Two alternative outcomes might be predicted. The first is that the profiles of TCR expression within antigen-specific T cell populations vary with tetramer availability. This finding would suggest that a responding CD8 ϩ set consists of TCR clonotypes with a broad range of TCR affinities, and that high-affinity TCR clonotypes can be selected under conditions of limiting tetramer concentration. Furthermore, these results would indicate that particular TCR clonotypes (or affinities) contribute significantly to the overall avidity of a virus-specific CD8 ϩ T cell pool. The second alternative is that there may be no such pattern of TCR selection correlating with tetramer dilution, suggesting that all TCR clonotypes are within a narrow range of affinities for the particular pMHC complex and that factors other than TCR affinity are the major determinants of any difference in avidity. The present analysis tests these two possibilities for TCR clonal selection in high-avidity virus-specific responses.
Methods
Mice and Viral Infection. Female C57BL͞6J (B6, H2 b ) mice were bred at the University of Melbourne. All of the experiments were carried out according to the guidelines of the Animal Ethics Experimentation Committee at the University of Melbourne. Naïve mice were anesthetized at 6-8 weeks of age by isofluorane inhalation and infected intranasally with 10 4 pfu of the HKx31 (H3N2) influenza A virus (26) in 30 l of PBS. ''Memory'' mice were primed i.p. with 1.5 ϫ 10 7 pfu of the serologically distinct PR8 (H1N1) influenza A virus that shares the NP and PA proteins of HKx31 (27, 28) . They were then challenged intranasally with the HKx31 virus at least 6 weeks later to generate a secondary response. Both virus stocks were grown in the allantoic cavity of 10-d embryonated hen's eggs and stored at Ϫ80°C. Virus titres were determined as pfu on monolayers of Madin Darby canine kidney cells.
Tissue Sampling and T Cell Enrichment. The spleen and bronchoalveolar lavage populations were recovered from mice at the peak of the primary or secondary response (d10 and d8, respectively). Lymphocytes from bronchoalveolar lavage of the infected lung were incubated on plastic Petri dishes for 1 h at 37°C to remove macrophages (27) . The spleens were disrupted, and the CD8 ϩ T cells were enriched by panning on goat anti-mouse IgG and IgM antibody-coated plates (Jackson ImmunoResearch).
Tetramer Dilution Analysis. Enriched T cell populations were stained with either the D b NP 366 or D b PA 224 tetramers, conjugated to Streptavidin-PE (Molecular Probes) at 1:100 to select the total epitope-specific population, or at dilutions ranging from 1:1,000 to 1:20,000 to define the sets that bind under conditions of limited tetramer availability. Lymphocytes (2 ϫ 10 7 cells per ml) were incubated with the tetramer for 60 min at room temperature, followed by two washes in sort buffer (0.1% BSA in PBS), then stained with anti-CD8␣-APC, and anti-V␤8.3-or anti-V␤7-FITC (Pharmingen) for 30 min on ice and two further washes. The stained cells were resuspended in 500 l of sort buffer and transferred to polypropylene FACS tubes (BD Labware, Franklin Lakes, NJ) for subsequent sorting experiments. Negative controls were interspersed between the samples (1 in 10), and 80 cells were sorted per plate. The cDNA mix contained 0.25 l Sensiscript reverse transcriptase, 1ϫ cDNA buffer, 0.5 mM dNTPs (Qiagen, Hilden, Germany), 0.125 g oligo dT (15) (Promega), 100 g͞ml gelatin (Roche, Indianapolis), 100 g͞ml tRNA (Roche Diagnostics), 20 units of RNAsin (Invitrogen), and 0.1% Triton-X100 (Sigma). After sorting, plates were incubated at 37°C for 90 min for cDNA synthesis, followed by 5 min at 95°C to stop reverse transcriptase activity. The V␤8.3 ϩ and V␤7 ϩ transcripts were amplified and sequenced as described in refs. 21 and 22. Earlier studies (13, 14) Fig. 1 A and B) . The analysis of TCR usage profiles thus concentrated on the epitope-specific sets recovered at the 1:100 (total) and 1:10,000 (limiting) dilutions. The single-cell TCR analysis that follows used spleen cells from five mice, two from a Tables 1 and 2 . Overall, a pattern of increased J␤1.5 (55%) and J␤2.6 (46%) usage was detected in the 1:10,000 CD8 ϩ D b PA 224 ϩ V␤7 ϩ population, whereas the prevalence of CDR3␤s with a 6-aa length was decreased by 20%, and the numbers with a 7-aa length were increased by 77%. The results suggest that a subset of CD8 ϩ D b PA 224 ϩ V␤7 ϩ T cells is being selected at limiting dilution, whereas this fact is not true for the CD8 ϩ D b NP 366 ϩ V␤8.3 ϩ response. If we were using the spectratyping approach (29, 30) to determine clonality rather than single-cell TCR sequencing, this J␤͞CDR3␤ analysis would represent the limit of acuity for this study. Results show the sequences and predominance of the prominent clonotypes in 1:10,000 populations and their frequencies in total 1:100 CD8 ϩ D b PA224 ϩ V␤7 ϩ cells for all five mice described in Fig. 2 legend. M1-M5 correspond to individual mice. (Fig. 2 A) . However, the 15ϩ clonotypes in the CD8 ϩ D b PA 224 ϩ V␤7 ϩ set were detected only at the 1:10,000 dilution (Fig. 2B) , demonstrating an increase in clonotype size. The mean size for these high-avidity CD8 ϩ D b PA 224 ϩ V␤7 ϩ 15ϩ clonotypes (Fig. 2B ) was 21.4 Ϯ 6.3 (n ϭ 6), whereas the comparable value for the ''total'' population that predominated in the 10-14 group was 12.0 Ϯ 1.5 (n ϭ 6), representing a highly significant difference (P Ͻ 0.006). On the other hand, the clone sizes for the 15ϩ CD8 ϩ D b NP 366 ϩ V␤8.3 ϩ sets (Fig. 2 A) were 30.3 Ϯ 10.5 (n ϭ 6) at 1:100 and 29.8 Ϯ 15.1 at 1:10,000 (n ϭ 6). Again, as with the J␤ usage and CDR3␤ length analysis, staining under conditions of limiting tetramer availability seems to be selecting a particular subset of T cells from the CD8 ϩ D b PA 224 ϩ V␤7 ϩ but not from the CD8 ϩ D b NP 366 ϩ V␤8.3 ϩ population (Fig. 2) .
TCR Characteristics of Individual Clones. The frequencies of individual clonotypes found at the 1:100 and 1:10,000 tetramer concentrations were then compared to determine the relative prevalence of the high-avidity TCRs in the total tetramer ϩ T cell pools. When the analysis was performed for the two largest CD8 ϩ D b PA 224 ϩ V␤7 ϩ clonotypes detected in each individual mouse at 1:10,000 dilution, the relative frequencies for 9 of 9 clonotypes were higher at 1:10,000 than 1:100, with the difference being Ͼ10ϫ in 2 of 9 and Ͼ2ϫ in 6 of 9 clonotypes (Table 1 ). These differences in prevalence for particular clonotypes found in the 1:100 and 1:10,000 sets were highly significant (P Ͻ 0.0039, Wilcoxon test, Fig. 3 ). Furthermore, the major clonotypes detected at 1:10,000 were often relatively rare in the 1:100 population, with 60% being found at frequencies Ͻ 8% in the total pool, suggesting that the predominant high-avidity CD8 (Table 2) , two of the largest clones that were found in more than one individual (SGGSNTGQL and SGGANTGQL) expressed public TCRs that are recovered regularly from different mice (22) . Unlike the situation for the CD8 ϩ D b PA 224 ϩ V␤7 ϩ set, these large CD8 ϩ D b NP 366 ϩ V␤8.3 ϩ clones were at relatively greater frequency in the total 1:100 set for 4 of 9 clonotypes, whereas the difference between the 1:100 and 1:10,000 sets was Ͻ2ϫ for 8 of 9 clonotypes (Fig. 4) . The exceptions were the private SDAMTGAGNTL (M5) The frequencies for the predominant two clonotypes in the high-avidity CD8 ϩ D b NP366 ϩ V␤8.3 ϩ population were analyzed for their respective frequencies in the total CD8 ϩ D b NP366 ϩ V␤8.3 ϩ cells from five mice (M1-M5) as described in Fig. 2 legend. and the public SGGANTGQL, which were at substantially higher prevalence for the 1:10,000 dilution in 1 of 5 mice (M3). Overall, comparing the two largest clonotypes in each mouse, there was no significant increase in frequency between the 1:100 and 1:10,000 dilutions (P ϭ 0.91, Wilcoxon test, Fig. 4 ).
Clonotype Distribution Profiles for All T Cells. The size distributions for all clonotypes were then analyzed to compare the TCR repertoires detected at the 1:100 and 1:10,000 tetramer dilutions (Fig. 5) . To ascertain whether a response is dominated by a few large clonotypes or shows a more even distribution, we first ranked all of the clonotypes from each individual mouse according to size and plotted them from smallest to largest. The results for the distribution of CD8 ϩ D b PA 224 ϩ V␤7 ϩ clonotype frequencies are shown for a representative mouse in Fig. 6A , which is published as supporting information on the PNAS web site, where it can be seen that the high-avidity response is dominated by large clonotypes compared with the total response. To allow comparisons between different mice, where different numbers of clonotypes (i.e., distinct amino acid sequences) and clones (i.e., a total number of sequences) were observed, we normalized the number of clonotypes and clones. In  Fig. 6B , the data from Fig. 6A are transformed to show the proportion of the total clonotypes and clones in the response. For example, clonotype 1 in the total pool in Fig. 6A represents 1 of 17 (5.9%) of the total clonotypes and 1 of 39 (2.6%) of the total clones. Clonotype 2 in Fig. 6A is also 1 of 17 of the total clonotypes and 1 of 39 of the total clones, so cumulatively, the two clonotypes represent 2 of 17 (11.7%) of the total clonotypes and 2 of 39 (5.1%) of the total clones. We then plot the third clonotype ranked according to size up to the 13th clonotype, which represents 100% of clonotypes and 100% of clones. By cumulating all of the clonotypes in this way for each mouse, we can see how much of the total repertoire is dominated by different clonotypes (Fig. 6B) .
The cumulative proportion of the total clonotypes within the spectrum of TCR repertoire usage (x axis, Fig. 5 ) was plotted against the cumulative proportion of the total clones (y axis, Fig.  5 ) for all of the clonotypes obtained in our study. As mentioned above, this type of analysis has the potential to provide information whether the response was dominated by a few large clonotypes or is of a more even distribution. If all clonotypes were of the same size, the plotted line in Fig. 5 would be a 45°d iagonal across the graph. On the other hand, a response that is dominated a few, large clonotypes will give a highly convex plot bowed toward the x axis. The closest to the straight line scenario was seen for the total 1:100 CD8 ϩ D b PA 224 ϩ V␤7 ϩ set (filled squares, Fig. 5 ), indicating that the clone size distribution is much more even than for the other groups (filled circles, The level of ''skewing'' of the clone size distribution toward the use of a few large clonotypes was then analyzed by estimating the proportion of the total clones observed (read from the y axis) that was constituted by the smallest 50% of the total clonotypes (estimated from the x axis by using linear interpolation where there was an odd number for a particular T cell set) (Fig.  5) . The smallest 50% of clonotypes of the total (1:100) CD8 ϩ D b PA 224 ϩ V␤7 ϩ pool took up a mean of 19.0% of the total clones, which was significantly higher than the proportion observed with the ''limiting'' (1:10, 224 -specific clonotypes in the highavidity set were found in the total populations at much lower frequencies. The implication is thus that T cells expressing highaffinity TCRs are more likely to be dominant within a response that incorporates a broad spectrum of TCR-pMHC affinities. Conversely, because the largest clonotypes in the CD8 ϩ D b NP 366 ϩ V␤8.3 ϩ populations were not selected on the basis of TCR affinity, other mechanisms are likely to be the predominant determinants of avidity for these epitope-specific CD8 ϩ T cells. Because our previous results showed a significantly higher dependence of CD8 ϩ D b NP 366 ϩ cells on CD8␤ binding when compared with the CD8 ϩ D b PA 224 ϩ population (19), we can speculate here that it is the CD8␤ that provides a major contribution to the overall avidity of the CD8 ϩ D b NP 366 ϩ set. Recent structural analyses (31, 32) have established that the D b PA 224 epitope is characterized by a prominent P7-arginine, whereas D b NP 366 is relatively flat and featureless with residues at positions 4, 6, and 7 oriented toward the MHC helices (33) . It was proposed (32) that an appropriate TCR ''fit'' with D b NP 366 is probably harder to achieve and, thus, D b NP 366 selects a much less diverse, and more public spectrum of TCRs than D b PA 224 . Modifying the P7-arginine to a less obtrusive alanine generates a topographically ''flatter,'' but still immunogenic, P7Ala-D b PA 224 epitope that, after infection with the modified virus, leads to the selection of a less-diverse TCR repertoire (32) . The structural studies raise the possibility that the TCR-pMHC fit for the ''featureless'' D b NP 366 epitope may lead to selection of a restricted repertoire, and as suggested by this study, the responding TCR clonotypes might be of approximately equivalent affinities. Conversely, the TCR repertoire selected by D b PA 224 is both diverse and, unlike the response to D b NP 366 , essentially private in character. This substantially greater diversity again fits with the idea that the TCR constraints governing the recognition of the ''prominent'' D b PA 224 are indeed less demanding than those required for the featureless D b NP 366 (32) . Given the greater diversity of the response, it is hardly surprising that a much broader spectrum of TCR-pMHC affinities would be found for the D b PA 224 -specific T cell populations. It is thus reasonable to assume that staining with the D b PA 224 tetramer under limiting conditions is indeed selecting highavidity T cells with a major contribution from high-affinity TCR␣␤-MHC interactions. A specific selection of the highaffinity TCR clonotypes in the high-avidity D b PA 224 ϩ population from clonotypes found at relatively low frequencies in the total D b PA 224 -specific pool further shows the specificity of our assay, and also suggests that the recruitment of these low-frequency, high-affinity TCR clonotypes occurred at the later time points of the response. No comparable discrimination could be demonstrated for the D b NP 366 -specific set, presumably because the breadth of diversity is insufficient to distinguish between total and high-avidity cells.
In our analysis, avidity is defined by the interaction between tetrameric pMHC complexes in solution and clonotypic TCR␣␤ heterodimers expressed on CD8 ϩ T cells. Although additional molecular interfaces may well contribute to the precise targeting of virus-specific CD8 ϩ effectors to virus-infected cells, the obvious variable that is likely to determine the strength and stability of the T cell-tetramer equation is the affinity of TCR␣␤-pMHC binding. The only variable analyzed here is the profile of CDR3␤ involvement. The attribution of clonotypes on the basis of CDR3␤ chain amino acid sequences makes sense when discussing TCR-pMHC affinity characteristics and is completely valid for the CD8 ϩ D b PA 224 ϩ V␤7 ϩ T cells where each CDR3␤ is defined by a single nucleotide sequence. However, all of the public and repeated clonotypes that were prominent in the CD8 ϩ D b NP 366 ϩ V␤8.3 ϩ sets consisted of two or three different ''clones'' on the basis of nucleotide diversity. The true ''identifier'' of a clone is clearly the nucleotide rather than the amino acid sequence. Each such clone will presumably be associated with a single TCR␣ chain. When the selection profiles at limiting and ''saturating'' tetramer concentrations were compared for clones defined by CDR3␤ nucleotide sequence, we again found no patterning for the CD8 ϩ D b NP 366 ϩ V␤8.3 ϩ response. This indirect measure of possible TCR␣ diversity suggests that some major and reproducible (from mouse to mouse) partitioning of TCR-pMHC binding mediated through the CDR3␣ chain is not being missed in the current experiments.
Taken together, our study suggests that the contribution of TCR clonotypes (i.e., affinities) to the overall avidity of CD8 ϩ T cells depends on the extent of clonal TCR␤ diversity within the particular epitope, and that in the absence of TCR diversity, non-TCR affinity determinants of avidity can make a significant contribution to overall avidity.
